EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitNetzwerk-Metaanalyse

Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis

Rituparna Maiti iD, Archana Mishra iD, Anand Srinivasan iD, Biswa Ranjan Mishra iD

Acta Psychiatrica Scandinavica · 2023

DOI: 10.1111/acps.13568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Psychiatrica Scandinavica, 2023. Verfasst von Rituparna Maiti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Obsessive-Compulsive Disorder. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The augmentation of serotonin reuptake inhibitors (SRIs) can be achieved by add‐on therapy with different pharmacological agents in obsessive–compulsive disorder (OCD) for a better clinical outcome. This network meta‐analysis (NMA) was conducted to evaluate and compare the effects of available augmentation agents for SRIs in OCD.

Method

The data was extracted from 59 relevant clinical trials after a literature search on MEDLINE/PubMed, Scopus, Cochrane databases and clinical trial registries. PRISMA guidelines were followed in data extraction, analysis and reporting. Random effects Bayesian NMA was done to pool the effects across the interventions for the change in Yale‐Brown Obsessive–Compulsive Scale (YBOCS) scoring from baseline to the end of the study. Network graph was built, consistency model was run, node splitting analysis was performed, treatments were ranked as per SUCRA score and meta‐regression was done for refractoriness to SRIs and duration of augmentation therapy as the predictor variables.

Results

The drugs showing significant reduction in YBOCS scoring were pregabalin (MD:−8.1;95% CrI: −16, −0.43), memantine (MD:−6.2;95% CrI: −9.9, −2.3), lamotrigine (MD:−6;95% CrI: −12, −0.47), ondansetron (MD:−5.7;95% CrI: −11, −0.67), granisetron (MD:−5.6;95% CrI: −11, −0.44), aripiprazole (MD:−5.4;95% CrI:−9.1, −1.6), risperidone (MD:−3.3;95% CrI: −6.4, −0.20) and topiramate (MD:−5.3;95% CrI: −9.6, −0.97). The node‐split analysis showed that direct and indirect pooled effect sizes for all comparisons were comparable. Meta‐regression showed a statistically non‐significant association between YBOCS score reduction with the duration of augmentation therapy, but significant with SRI‐refractory status. Finally, the results were sorted based on certainty of evidence.

Conclusion

Memantine was found to be most effective augmentation agent for SRIs in OCD, followed by lamotrigine, ondansetron and granisetron with moderate certainty of evidence. The augmentation agents showed better symptom reduction in patients with SRI‐refractory OCD in comparison to non‐refractory OCD. PROSPERO registration CRD42022360110.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Selective Serotonin Reuptake InhibitorsObsessive-Compulsive DisorderHumansOndansetronDrug Therapy, CombinationLamotrigineBayes TheoremGranisetronMemantineTreatment Outcome

Stichwörter der Autor:innen

Yale-Brown Obsessive-Compulsive Scaleaugmentationobsessive-compulsive disorderserotonin reuptake inhibitor

Substanzen

Selective Serotonin Reuptake InhibitorsOndansetronLamotrigineGranisetronMemantine

Autor:innen und Institutionen

  • Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
  • Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.

ORCID-Profile: Rituparna Maiti, Archana Mishra, Anand Srinivasan, Biswa Ranjan Mishra

Zitieren

APA

Maiti, R., Mishra, A., Srinivasan, A., & Mishra, B. R. (2023). Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13568

Vancouver

Maiti R, Mishra A, Srinivasan A, Mishra BR. Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis. Acta Psychiatrica Scandinavica. 2023. doi:10.1111/acps.13568

BibTeX
@article{Maiti2023,
  author = {Maiti, Rituparna and Mishra, Archana and Srinivasan, Anand and Mishra, Biswa Ranjan},
  title = {Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive–compulsive disorder: A network meta‐analysis},
  journal = {Acta Psychiatrica Scandinavica},
  year = {2023},
  doi = {10.1111/acps.13568}
}
Kostenlos starten →